{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:31:24Z","timestamp":1792452684528,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,19]]},"DOI":"10.7759\/cureus.10544","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T19:28:11Z","timestamp":1600543691000},"source":"Crossref","is-referenced-by-count":6,"title":["Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma"],"prefix":"10.7759","author":[{"given":"Kaushik","family":"Kondubhatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihan A","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury M","year":"2014","unstructured":"Fakhoury M, Negrulj R, Mooranian A, and Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014, 7:113-120. 10.2147\/JIR.S65979","journal-title":"J Inflamm Res"},{"key":"ref2","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian SS","year":"2019","unstructured":"Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019, 12:113-122.","journal-title":"J Med Life"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i40.11246","article-title":"Disease monitoring in inflammatory bowel disease","volume":"21","author":"Chang S","year":"2015","unstructured":"Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol. 2015, 21:11246-11259. 10.3748\/wjg.v21.i40.11246","journal-title":"World J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang YZ","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014, 20:91-99. 10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr2102w","article-title":"Inflammatory bowel disease as a risk factor for premature coronary artery disease","volume":"7","author":"Ruisi P","year":"2015","unstructured":"Ruisi P, Makaryus JN, Ruisi M, Makaryus AN. Inflammatory bowel disease as a risk factor for premature coronary artery disease. J Clin Med Res. 2015, 7:257-261. 10.14740\/jocmr2102w","journal-title":"J Clin Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000109","article-title":"Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease","volume":"20","author":"Aggarwal A","year":"2014","unstructured":"Aggarwal A, Atreja A, Kapadia S, Lopez R, Achkar JP. Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease. Inflamm Bowel Dis. 2014, 20:1593-1601. 10.1097\/MIB.0000000000000109","journal-title":"Inflamm Bowel Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2016.04.002","article-title":"Inflammation in atherosclerosis","volume":"109","author":"Taleb S","year":"2016","unstructured":"Taleb S. Inflammation in atherosclerosis. Arch Cardiovasc Dis. 2016, 109:708-715. 10.1016\/j.acvd.2016.04.002","journal-title":"Arch Cardiovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55060249","article-title":"Heart involvement in inflammatory rheumatic diseases: a systematic literature review","volume":"6","author":"Buleu F","year":"2019","unstructured":"Buleu F, Sirbu E, Caraba A, Dragan S. Heart involvement in inflammatory rheumatic diseases: a systematic literature review. Medicina (Kaunas). 2019, 6:249. 10.3390\/medicina55060249","journal-title":"Medicina (Kaunas)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy354","article-title":"Risk of myocardial infarction in inflammatory bowel disease: a population-based national study","volume":"4","author":"Panhwar MS","year":"2019","unstructured":"Panhwar MS, Mansoor E, Al-Kindi SG, et al.. Risk of myocardial infarction in inflammatory bowel disease: a population-based national study. Inflamm Bowel Dis. 2019, 4:1080-1087. 10.1093\/ibd\/izy354","journal-title":"Inflamm Bowel Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur AJ","year":"2011","unstructured":"Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011, 106:741-747. 10.1038\/ajg.2011.63","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.06.032","article-title":"No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn\u2019s disease","volume":"9","author":"Osterman MT","year":"2011","unstructured":"Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2011, 9:875-880. 10.1016\/j.cgh.2011.06.032","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref12","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study","volume":"5","author":"GBD 2017 Inflammatory Bowel Disease Collaborators","year":"2020","unstructured":"GBD 2017 Inflammatory Bowel Disease Collaborators . The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study. Lancet Gastroenterol Hepatol. 2020, 5:17-30.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8690-3","article-title":"Allergic and immunologic perspectives of inflammatory bowel disease","volume":"57","author":"Clarke K","year":"2019","unstructured":"Clarke K, Chintanaboina J. Allergic and immunologic perspectives of inflammatory bowel disease. Clin Rev Allergy Immunol. 2019, 57:179-193. 10.1007\/s12016-018-8690-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease? (In Press)","author":"Bigeh A","year":"2019","unstructured":"Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease? (In Press). Trends Cardiovasc Med. 2019, 10.1016\/j.tcm.2019.10.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/fg.2010.001487","article-title":"The impact of smoking in Crohn\u2019s disease: no smoke without fire","volume":"3","author":"Aldhous MC","year":"2010","unstructured":"Aldhous MC, Satsangi J. The impact of smoking in Crohn\u2019s disease: no smoke without fire. Frontline Gastroenterol. 2010, 3:156-164. 10.1136\/fg.2010.001487","journal-title":"Frontline Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809090183","article-title":"Effects of cigarette smoking on the clinical course of ulcerative colitis","volume":"23","author":"Boyko EJ","year":"1988","unstructured":"Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scandinavian Journal of Gastroenterology. 1988, 23:1147-1152. 10.3109\/00365528809090183","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000320395","article-title":"Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD","volume":"28","author":"Cosnes J","year":"2010","unstructured":"Cosnes J. Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD. Dig Dis. 2010, 28:411-417. 10.1159\/000320395","journal-title":"Dig Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.88","article-title":"Gut microbiota and IBD: causation or correlation?","volume":"14","author":"Ni J","year":"2017","unstructured":"Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation?. Nat Rev Gastroenterol Hepatol. 2017, 14:573-584. 10.1038\/nrgastro.2017.88","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida A","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018, 11:1-10. 10.1007\/s12328-017-0813-5","journal-title":"Clin J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000447252","article-title":"Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation?","volume":"1","author":"Fukui H","year":"2016","unstructured":"Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation?. Inflamm Intest Dis. 2016, 1:135-145. 10.1159\/000447252","journal-title":"Inflamm Intest Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht271","article-title":"The heart and the gut","volume":"35","author":"Rogler G","year":"2014","unstructured":"Rogler G, Rosano G. The heart and the gut. Eur Heart J. 2014, 35:426-430. 10.1093\/eurheartj\/eht271","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober W","year":"2011","unstructured":"Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011, 140:1756-1767. 10.1053\/j.gastro.2011.02.016","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham C","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009, 361:2066-2078. 10.1056\/NEJMra0804647","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"12","author":"Geovanini GR","year":"2018","unstructured":"Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018, 12:1243-1252. 10.1042\/CS20180306","journal-title":"Clin Sci (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"345","author":"The Emerging Risk Factors Collaboration","year":"2010","unstructured":"The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010 , 345:132-140. 10.1016\/S0140-6736(09)61717-7","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby P","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009, 54:2129-2138. 10.1016\/j.jacc.2009.09.009","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033442","article-title":"Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden","volume":"7","author":"Z\u00f6ller B","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K. Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One. 2012, 7:33442. 10.1371\/journal.pone.0033442","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15021","article-title":"Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study","volume":"32","author":"Leisner MZ","year":"2018","unstructured":"Leisner MZ, Lindorff Riis J, Gniadecki R, Iversen L, Olsen M. Psoriasis and risk of myocardial infarction before and during an era with biological therapy: a population-based follow-up study. J Eur Acad Dermatol Venereol. 2018, 32:2185-2190. 10.1111\/jdv.15021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge M","year":"2010","unstructured":"Grainge M, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010, 375:657-663. 10.1016\/S0140-6736(09)61963-2","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314015","article-title":"Increased risk of acute arterial events in young patients and severely active IBD: a nationwide french cohort study","volume":"67","author":"Kirchgesner J","year":"2018","unstructured":"Kirchgesner J, Beaugerie L, Carrat F. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide french cohort study. Gut. 2018, 67:1261-1268. 10.1136\/gutjnl-2017-314015","journal-title":"Gut"},{"key":"ref31","article-title":"The vasculature and inflammatory bowel disease. contribution to pathogenesis and clinical pathology","volume":"11","author":"Hatoum OA","year":"2005","unstructured":"Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease. contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis. 2005, 11:304-313. https:\/\/doi.org\/10.1097\/01.MIB.0000160772.78951.61","journal-title":"Inflamm Bowel Dis"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005892","article-title":"Inflammatory bowel disease and risk of ischemic heart disease: an updated meta\u2010analysis of cohort studies","volume":"6","author":"Feng W","year":"2017","unstructured":"Feng W, Chen G, Cai D, Zhao S, Cheng J and Shen H. Inflammatory bowel disease and risk of ischemic heart disease: an updated meta\u2010analysis of cohort studies. JAHA. 2017, 6:e005892.","journal-title":"JAHA"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0003319709333869","article-title":"Is inflammatory bowel disease a risk factor for early atherosclerosis?","volume":"61","author":"Dagli N","year":"2010","unstructured":"Dagli N, Poyrazoglu OK, Dagli AF, Sahbaz F, Karaca I, Kobat MA, Bahcecioglu IH. Is inflammatory bowel disease a risk factor for early atherosclerosis?. Angiology. 2010, 61:198-204. 10.1177\/0003319709333869","journal-title":"Angiology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3012509","article-title":"Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies","volume":"2019","author":"Bunu DM","year":"2019","unstructured":"Bunu DM, Timofte CE, Ciocoiu M, Floria M, Tarniceriu CC, Barboi OB, Tanase DM. Cardiovascular manifestations of inflammatory bowel disease: pathogenesis, diagnosis, and preventive strategies. Gastroenterol Res Pract. 2019, 2019:3012509. 10.1155\/2019\/3012509","journal-title":"Gastroenterol Res Pract"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i33.9688","article-title":"Cardiovascular involvement in inflammatory bowel disease: dangerous liaisons","volume":"7","author":"Filimon AM","year":"2015","unstructured":"Filimon AM, Negreanu L, Doca M, Ciobanu A, Preda CM, Vinereanu D. Cardiovascular involvement in inflammatory bowel disease: dangerous liaisons. World J Gastroenterol. 2015, 7:9688-9692. 10.3748\/wjg.v21.i33.9688","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.202","article-title":"Epidemiology, risk factors and management of cardiovascular diseases in IBD","volume":"12","author":"Singh S","year":"2015","unstructured":"Singh S, Kullo IJ, Pardi DS, Loftus Jr EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol. 2015, 12:26-35. 10.1038\/nrgastro.2014.202","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref37","article-title":"Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database","volume":"22","author":"Barnes EL","year":"2016","unstructured":"Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW. Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database. Inflamm Bowel Dis. 2016, 22:2229-2237. https:\/\/doi.org\/10.1097\/MIB.0000000000000899","journal-title":"Inflamm Bowel Dis"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-020-00821-0","article-title":"Gut microbiota and cardiovascular disease: opportunities and challenges","volume":"8","author":"Kazemian N","year":"2020","unstructured":"Kazemian N, Mahmoudi M, Halperin F, Wu J, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020, 8:36.","journal-title":"Microbiome"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-015-0100-y","article-title":"In silico analyses of metagenomes from human atherosclerotic plaque samples","volume":"3","author":"Mitra S","year":"2015","unstructured":"Mitra S, Drautz-moses DI, Alhede M, et al.. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome. 2015, 3:38. 10.1186\/s40168-015-0100-y","journal-title":"Microbiome"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14195","article-title":"The role of intestinal microbiota in cardiovascular disease","volume":"23","author":"Jin M","year":"2019","unstructured":"Jin M, Qian Z, Yin J, Xu W, Zhou X. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med. 2019, 23:2343-2350. 10.1111\/jcmm.14195","journal-title":"J Cell Mol Med"},{"key":"ref41","article-title":"The gut microbiome contributes to a substantial proportion of the variation in blood lipids","volume":"117","author":"Fu J","year":"2015","unstructured":"Fu J, Bonder MJ, Cenit MC, et al.. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015, 117:817-824.","journal-title":"Circ Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00350","article-title":"Elevated circulating trimethylamine n-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress","volume":"8","author":"Li T","year":"2017","unstructured":"Li T, Chen Y, Gua C, Li X. Elevated circulating trimethylamine n-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress. Front Physiol. 2017, 8:350.  10.3389\/fphys.2017.00350","journal-title":"Front Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/38740-pro-atherogenic-inflammatory-mediators-in-inflammatory-bowel-disease-patients-increase-the-risk-of-thrombosis-coronary-artery-disease-and-myocardial-infarction-a-scientific-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:48Z","timestamp":1707506808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/38740-pro-atherogenic-inflammatory-mediators-in-inflammatory-bowel-disease-patients-increase-the-risk-of-thrombosis-coronary-artery-disease-and-myocardial-infarction-a-scientific-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.10544","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,19]]}}}